Researcher
Pieter Gillard
- Keywords:Medicine
- Disciplines:Other basic sciences not elsewhere classified
Affiliations
- Diabetes Pathology & Therapy (Research group)
Member
From2 Feb 2011 → Today - Diabetes Clinic (Department)
Member
From1 Nov 2008 → Today - Clinical sciences (Department)
Member
From1 Oct 2023 → Today - Pathology/molecular and cellular medicine (Department)
Member
From1 Oct 2018 → 20 Oct 2022 - Pathology/molecular and cellular medicine (Department)
Member
From1 Aug 2014 → 30 Sep 2023 - Pathology/molecular and cellular medicine (Department)
Member
From1 Aug 2014 → 31 Jul 2018 - Internal medicine (Department)
Member
From1 Jan 2008 → 31 Jan 2008 - Department of Embryology and Genetics (Department)
Member
From1 Feb 2002 → 31 Jan 2006
Publications
1 - 10 of 54
- Baseline plasma proinsulin response to glucose for predicting therapeutic response to otelixizumab in recent-onset type 1 diabetes(2023)
Authors: Aster K Desouter, Bart Keymeulen, Simke Demeester, Pieter De Pauw, A Van Dalem, Bruno Lapauw, Christophe De Block, Pieter Gillard, Danny Pipeleers, Frans K Gorus
- Post hoc analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes(2023)
Authors: Valeria Sordi, Paolo Monti, Vito Lampasona, Raffaella Melzi, Silvia Pellegrini, Bart Keymeulen, Pieter Gillard, Thomas Linn, Emanuele Bosi, Ludger Rose, et al.
- CTLA4, SH2B3 and CLEC16A diversely affect the progression of early islet autoimmunity in relatives of type 1 diabetes patients(2023)
Authors: Julie Vandewalle, Aster K Desouter, Bart J Van der Auwera, Sylvie Tenoutasse, Pieter Gillard, Christophe De Block, Bart Keymeulen, Frans K Gorus, Mark Van De Casteele
Pages: 224-232 - Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes(2023)
Authors: Margaretha M Visser, Sara Charleer, Steffen Fieuws, Christophe De Block, Robert Hilbrands, Liesbeth Van Huffel, Toon Maes, Gerd Vanhaverbeke, Eveline Dirinck, Nele Myngheer, et al.
Pages: 96-108 - Effect of nationwide reimbursement of real-time continuous glucose monitoring on HbA1c, hypoglycemia and quality of life in a pediatric type 1 diabetes population(2022)
Authors: Francesca De Ridder, Sara Charleer, Seppe Jacobs, Nancy Bolsens, Kristien J. Ledeganck, Sara Van Aken, Jesse Vanbesien, Inge Gies, Kristina Casteels, Guy Massa, et al.
- Diabetic Ketoacidosis After Sodium–Glucose Cotransporter Inhibitor Initiation Under Advanced Hybrid Closed-Loop Therapy in Type 1 Diabetes(2022)
Authors: Margaretha M Visser, Chantal Mathieu, Pieter Gillard
Pages: 516-519 - Utility of islet cell preparations from donor pancreases after euthanasia(2022)
Authors: Diedert L De Paep, Freya Van Hulle, Zhidong Ling, Marian Vanhoeij, Robert Hilbrands, Wim Distelmans, Pieter Gillard, Bart Keymeulen, Daniel Pipeleers, Daniel Jacobs-Tulleneers-Thevissen
Pages: 9636897221096160 - Cardiometabolic and Kidney Protection in Kidney Transplant Recipients with Diabetes(2022)
Authors: Vikas S Sridhar, Jaya Prakash N Ambinathan, Pieter Gillard, Chantal Mathieu, David Z I Cherney, Yuliya Lytvyn, Sunita K Singh
Pages: 734-748 - Function and composition of pancreatic islet cell implants in omentum of type 1 diabetes patients(2022)
Authors: Freya Van Hulle, Kaat De Groot, Robert Hilbrands, Krista G Suenens, Geert M Stangé, Ines De Mesmaeker, Diedert L De Paep, Zhidong Ling, Bart O Roep, Pieter Gillard, et al.
Pages: 927-936 - Relationship between time in range, glycemic variability, HbA1c and complications in adults with type 1 diabetes mellitus(2022)
Authors: Anass El Malahi, Michiel Van Elsen, Sara Charleer, Eveline Dirinck, Kristien J. Ledeganck, Bart Keymeulen, Laurent Crenier, Régis P Radermecker, Youri Taes, Chris Vercammen, et al.
Pages: e570-e581